Multifunctional Nanoparticles for Anticancer Drug Delivery Systems
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Nanochemistry".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 1086
Special Issue Editor
Interests: nanoparticles; drug delivery; nanocarriers; cancer therapy; computational modeling; nanomaterials; cancer biology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The field of nanotechnology has led to the development of many innovative strategies for the effective detection and treatment of cancer, overcoming limitations associated with conventional cancer diagnosis and therapy. Compared to conventional chemotherapy, targeted drug delivery systems are advantageous in many ways as they minimize drug resistance and improve therapeutic value for cancer patients. Moreover, multifunctional nanoparticle-based platforms of anticancer drug delivery have paved the way for innovative therapies that are more efficacious, less invasive, and less toxic.
Multifunctional nanoparticles enable the simultaneous delivery of multiple treatment agents, resulting in effective combinatorial therapeutic regimens against cancer. Multifunctional nanoparticles can also be loaded with imaging agents or molecules to provide diagnostic information during optical imaging, magnetic resonance, and photothermal detection. Overall, they can be engineered to detect cancer cells, deliver treatment agents, and monitor treatment response, thus integrating diagnosis and treatment in real time.
For this Special Issue, we discuss the various types of materials used to synthesize multifunctional nanoparticles for cancer imaging and therapy and summarize recent and ongoing research in the fabrication of these designer NPs against cancer. We highlight the three main components that make up a multifunctional NP in cancer drug delivery and imaging: the targeting ligand, the anticancer therapeutic agent, and the imaging modality.
Dr. Amr Amin
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer therapy
- drug delivery
- multifunctional nanoparticles
- nanotechnology
- tumor targeting
- imaging
